BlueChip Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-286
Closed -$218K 165
2025
Q3
$218K Buy
+286
New +$213K 0.09% 149
2024
Q4
Sell
-427
Closed -$379K 151
2024
Q3
$379K Buy
427
+9
+2% +$8.09K 0.2% 102
2024
Q2
$379K Buy
+418
New +$334K 0.22% 89
2024
Q1
Sell
-566
Closed -$330K 128
2023
Q4
$330K Buy
+566
New +$330K 0.23% 83

Other funds holding LLY

BlueChip Wealth Advisors's LLY Position: Q4 2025 in Review

BlueChip Wealth Advisors sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 286 shares — an estimated $218K sold.

BlueChip Wealth Advisors first reported a position in LLY in Q4 2023 and held it in 4 quarters. The position peaked at $379K in Q2 2024. 4,441 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • BlueChip Wealth Advisors reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • BlueChip Wealth Advisors sold 286 Eli Lilly shares in Q4 2025, an estimated $218K.
  • BlueChip Wealth Advisors first reported a position in Eli Lilly in Q4 2023 and held it in 4 quarters.
  • BlueChip Wealth Advisors's Eli Lilly position peaked at $379K in Q2 2024.
  • 4,441 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on BlueChip Wealth Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.